News

NHS England launches consultation on innovative radiotherapy treatments

NHS England is seeking people’s views on proposed changes to the shape of Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) services across the country. SRS and SRT are forms of radiotherapy used to treat patients with intracranial conditions such as brain tumours. NHS England took on responsibility for commissioning these services in April 2013 and […]

Read more

NHS England consults on plans for a sustainable Cancer Drugs Fund

NHS England is proposing changes to the way its Cancer Drugs Fund (CDF) operates, in order that it delivers maximum benefit for patients, within the resources available. Clinicians and cancer specialists believe the changes, if adopted, would: improve patient access to the most clinically effective drugs available through the fund; encourage pricing that delivers value […]

Read more

Cancer patients increasingly positive about their care

Cancer patients are increasingly positive about their care with 89% rating it as excellent or very good, a national survey shows. This comes as the NHS is treating more patients for cancer than ever before. The national cancer patient experience survey 2014, published today, asked over 110,000 cancer patients across the country for their views on […]

Read more

NHS England statement in response to Independent article on Czech proton clinic

NHS England has issued the following statement in response to an article in the Independent today (Saturday 6 September), which claims the NHS ignored offers of therapy at a Czech proton clinic. A Spokesperson from NHS England said: “The NHS has secured adequate capacity in established high quality international proton beam treatment centres.  These have […]

Read more

NHS England praises NHS for referring more cancer patients early and calls for action to address waiting time pressures

NHS England today (Friday) praised NHS staff for referring and treating an increasing number of patients for cancer as more people step forward for treatment early. Publishing the latest statistics on cancer waiting time standards, it said a welcome rise in referrals and treatment rates had put pressure on hospitals. It announced the creation of […]

Read more

NHS England sets out plan for a sustainable Cancer Drugs Fund

NHS England has today pledged a £160m boost over two years for the Cancer Drugs Fund, giving more patients access to innovative drugs not routinely available on the NHS. Two new drugs will now also be added to the Fund; enzalutamide for prostate cancer and lenalidomide for a group of patients with myelodysplastic syndrome, a […]

Read more

UK to lead the world in the fight against cancer and rare diseases

The UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated, thanks to£300million of investment, the Prime Minister announced today (1 August). The four year project will allow scientists to do pioneering new research to decode 100,000 human genomes […]

Read more

NHS England backs cancer campaign

NHS England is supporting a campaign launched by The Sunday Times newspaper, which aims at improving cancer care. The campaign focuses on swifter diagnosis, faster and more consistent treatment across the country and more advanced radiotherapy. National Medical Director, Professor Sir Bruce Keogh, said NHS England has ambitions to raise cancer survival to match the […]

Read more

Three new drugs added to Cancer Drugs Fund will treat 900 patients a year

Nine hundred cancer patients every year could benefit from three new drugs which have been added to the Cancer Drugs Fund. The drugs Albumin Bound Paclitaxel, Bevacizumab and Cabozantinib are to be used to treat pancreatic cancer, brain tumours in children and thryroid cancer respectively. Albumin Bound Paclitaxel(this document is no longer available here but […]

Read more